Reduced ERBB4 expression was confirmed by IHC in CHLA-9 control implantation site tumours compared to strong ERBB4 immunostaining in both CHLA-9/ERBB4 implantation site and metastatic tumours (Fig 7). Here, ERBB4 is linked to neoplasm.